Doroodgar Farideh, Niazi Sana, Mazloomi Maedeh, Mohammadi Farzad, Feizi Sepehr
Negah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Translational Ophthalmic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
J Cataract Refract Surg. 2025 Sep 22. doi: 10.1097/j.jcrs.0000000000001791.
This comprehensive systematic review addresses how concurrent ocular surface diseases (OSDs) in keratoconus (KC) patients affect KC's development, progression, diagnostic evaluation, and management, as well as KC's effect on ocular surface disturbance. This review integrates findings to bridge the gap between basic KC pathophysiology and its practical clinical management to provide a structured framework for optimizing KC treatment.
This study represents the first systematic effort to operationally synthesize existing knowledge on the interplay between OSDs and KC, offering actionable insights for clinicians. OSDs are not only recognized contributors to KC onset but are also major factors in treatment failure, making their evaluation critical in KC management.
A systematic search was conducted in Scopus, PubMed, Cochrane, Embase, and Web of Science for studies published up to February 2025. Studies were included regardless of language, provided they met predefined relevance and quality criteria. Exclusion criteria included replies, commentaries, case studies, retracted studies, ex vivo investigations, and studies scoring low on the AMSTAR checklist.
Initially, 9,572 records were identified; 5,337 duplicates were removed, leaving 4,235 for screening. After title and abstract review, 576 full texts were assessed, with 372 excluded based on AMSTAR scores or study type, leaving 204 studies. Findings highlight that OSDs significantly impact KC pathogenesis and clinical management. Non-ectatic conditions such as dry eye and tear film instability are increasingly included in the differential diagnosis of KC, emphasizing the need for a multidisciplinary approach. OSDs not only contribute to KC progression but also complicate diagnostic interpretations and influence treatment efficacy.
The ocular surface plays a pivotal role not only in KC pathogenesis but also in treatment success or failure. Thus, it is important to address concurrent OSDs in patients with KC as they can complicate its course. This is a vital consideration for treatment strategies. However, more studies on the causal link between KC and OSD are needed to help clinicians diagnose and manage these conditions better.
本全面的系统评价探讨了圆锥角膜(KC)患者并发的眼表疾病(OSD)如何影响KC的发展、进展、诊断评估和治疗,以及KC对眼表紊乱的影响。本评价整合了研究结果,以弥合KC基础病理生理学与其实际临床管理之间的差距,为优化KC治疗提供一个结构化框架。
本研究是首次系统地综合关于OSD与KC相互作用的现有知识,为临床医生提供可操作的见解。OSD不仅被认为是KC发病的促成因素,也是治疗失败的主要因素,因此对其评估在KC管理中至关重要。
在Scopus、PubMed、Cochrane、Embase和Web of Science中进行系统检索,查找截至2025年2月发表的研究。只要符合预定义的相关性和质量标准,无论语言如何,研究均被纳入。排除标准包括回复、评论、病例研究、撤稿研究、体外研究以及在AMSTAR清单上得分较低的研究。
最初识别出9572条记录;去除5337条重复记录后,剩余4235条进行筛选。经过标题和摘要审查,评估了576篇全文,基于AMSTAR评分或研究类型排除372篇,剩余204项研究。研究结果表明,OSD对KC发病机制和临床管理有显著影响。干眼和泪膜不稳定等非扩张性疾病越来越多地被纳入KC的鉴别诊断中,强调了多学科方法的必要性。OSD不仅促进KC进展,还使诊断解释复杂化并影响治疗效果。
眼表不仅在KC发病机制中起关键作用,而且在治疗成败中也起关键作用。因此,处理KC患者并发的OSD很重要,因为它们会使病程复杂化。这是治疗策略的一个重要考虑因素。然而,需要更多关于KC与OSD因果关系的研究,以帮助临床医生更好地诊断和管理这些病症。